The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

Related Keywords

Stanford , California , United States , New Jersey , Stanford University , Hackensack University Medical Center , Hackensack , La Jolla , San Francisco , Anthonys Fauci , Emily Henderson , Pei Yong Shi , Jeffrey Glenn , David Perlin , Reuben Harris , Nevan Krogan , Richard Plemper , Sumit Chanda , University Of California , Emory University , Antiviral Drug Development Initiative , National Institute Of Allergy , Stanford University School Of Medicine , Translational Sciences , Antiviral Program For Pandemics , Coronavirus Research Group Pandemic Response Program , Avidd Center , Midwest Avidd Center , University Of North Carolina At Chapel Hill , University Of Minnesota , Office Of Research Infrastructure Programs , Georgia State University , Antiviral Countermeasures Development Center , Development Of Outpatient Antiviral Cocktails , Scripps Research Institute , National Center , National Institutes Of Health , Biomedical Advanced Research , Development Authority , University Of Texas Medical Branch , Utmb Novartis Alliance For Pandemic Preparedness , National Institute , Infectious Diseases , National Institutes , Antiviral Drug Discovery , Antiviral Program , Advancing Translational Sciences , Research Infrastructure Programs , Antiviral Medicines , Novartis Alliance , Texas Medical Branch , Emerging Antiviral Drug Development Initiative , Ralph Baric , North Carolina , Outpatient Antiviral Cocktails , Potential Pandemic , Stanford University School , George Painter , Research Group Pandemic Response , Antiviral Drug , Allergy , Fell , Gold , Covid 19 , Drug Discovery , Drugs , Electron , Fever , Marburg Virus , Medical Research , Micrograph , Pandemic , Mh , Research , Cars , Ars Cov 2 , Virus , Yellow Fever ,